Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 301 to 350 of 2387

TitleReference numberPublishedLast updated
Breast cancerQS12
Breast reconstruction using lipomodelling after breast cancer treatmentIPG417
Brentuximab vedotin for treating CD30-positive cutaneous T-cell lymphomaTA577
Brentuximab vedotin for treating CD30-positive Hodgkin lymphomaTA524
Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphomaTA478
Brentuximab vedotin for untreated advanced Hodgkin lymphoma (terminated appraisal)TA594
Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphomaTA641
Brexucabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 26 years and overTA893
Brexucabtagene autoleucel for treating relapsed or refractory mantle cell lymphomaTA677
Brigatinib for ALK-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitorTA670
Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinibTA571
Brodalumab for treating moderate to severe plaque psoriasisTA511
Brolucizumab for treating diabetic macular oedemaTA820
Brolucizumab for treating wet age-related macular degenerationTA672
Bronchial thermoplasty for severe asthmaIPG635
Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribingNG117
Bronchiolitis in childrenQS122
Bronchiolitis in children: diagnosis and managementNG9
Bronchoscopic thermal vapour ablation for upper-lobe emphysemaIPG652
Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitisTA708
Bulevirtide for treating chronic hepatitis DTA896
Burosumab for treating X-linked hypophosphataemia in children and young peopleHST8
Butterfly iQ+ for diagnostic ultrasound imagingMIB254
C3 glomerulopathy in the native kidney: eculizumabESUOM49
Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxelTA391
Cabotegravir with rilpivirine for treating HIV-1TA757
Cabozantinib for previously treated advanced differentiated thyroid cancer unsuitable for or refractory to radioactive iodineTA928
Cabozantinib for previously treated advanced hepatocellular carcinomaTA849
Cabozantinib for previously treated advanced renal cell carcinomaTA463
Cabozantinib for treating medullary thyroid cancerTA516
Cabozantinib for untreated advanced renal cell carcinomaTA542
Cabozantinib with nivolumab for untreated advanced renal cell carcinomaTA964
CADScor system for ruling out coronary artery disease in people with symptoms of stable coronary artery diseaseMIB174
Caesarean birthNG192
Caesarean birthQS32
Canagliflozin in combination therapy for treating type 2 diabetesTA315
Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetesTA390
Canakinumab for treating systemic juvenile idiopathic arthritis (terminated appraisal)TA302
Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and overNG36
Cancer services for children and young peopleQS55
Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal)TA351
Cannabidiol for treating seizures caused by tuberous sclerosis complexTA873
Cannabidiol with clobazam for treating seizures associated with Dravet syndromeTA614
Cannabidiol with clobazam for treating seizures associated with Lennox–Gastaut syndromeTA615
Cannabis-based medicinal productsNG144
Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancerTA100
Capecitabine for the treatment of advanced gastric cancerTA191
Caplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpuraTA667
Capmatinib for treating advanced non-small-cell lung cancer with MET exon 14 skipping (terminated appraisal)TA884
Cardiac contractility modulation device implantation for heart failureIPG655

Results per page

  1. 10
  2. 25
  3. 50
  4. All